NASDAQ · MDLN
Medline Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for MDLN: Nov 04, 2026
Medline Inc. Class A Common Stock is expected to report earnings on 11/04/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $0.32.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.32 | $0.33 | $0.30 | 6 |
| Dec 2026 | $0.37 | $0.40 | $0.34 | 6 |
| Mar 2027 | $0.30 | $0.34 | $0.28 | 5 |
| Jun 2027 | $0.34 | $0.36 | $0.32 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · NASDAQ.com · MarketBeat · Zacks- The Motley Fool · Aug 12, 10:28 AM EDTMedline (MDLN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- NASDAQ.com · Aug 6, 4:24 PM EDTAfter Hours Most Active for Aug 6, 2026 : TTD, CMCSA, AAPL, AGNC, MDLN, CPNG, NU, NVDA, RKT, HDB, AXIA, HALThe NASDAQ 100 After Hours Indicator is up 20.06 to 29,393.39. The total After hours volume is currently 159,735,774 shares traded.The following are the most active stocks for the after hours session: The Trade Desk, Inc. (TTD) is -4.23 at $13.44, with 22,808,598 shares traded.
- MarketBeat · Aug 5, 1:04 PM EDTMedline Q2 Earnings Call HighlightsA Fresh IPO That Long-Term Investors Shouldn’t IgnoreMedline (NASDAQ:MDLN) reported second-quarter 2026 net sales growth of 12% to $7.7 billion, supported by demand across its medical-surgical product and supply-chain businesses, while raising its full-year organic sales outlook.
- Zacks · Aug 5, 9:30 AM EDTHere's What Key Metrics Tell Us About Medline (MDLN) Q2 EarningsAlthough the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- The Motley Fool · Jul 23, 7:09 AM EDTWhy Symbotic Stock Dropped 24% in the First Half of 2026 And Is a Screaming Buy NowSymbotic recently entered the healthcare sector with a new customer.
- Zacks · Jun 18, 11:40 AM EDTICUI or MDLN: Which Is the Better Value Stock Right Now?ICUI vs. MDLN: Which Stock Is the Better Value Option?
- The Motley Fool · Jun 8, 8:04 AM EDTWhy Symbotic Stock Slumped 21% in May And Just Hit a 2026 LowSymbotic is sitting on a massive backlog and recently signed a large customer.
- Barchart · May 20, 7:29 PM EDTStocks Climb on Lower Bond Yields and Chipmaker StrengthThe S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. June E-mini S&P futures (ESM26 ) are up +0.26%, and June E-mini Nasdaq futures…
- Barchart · May 20, 6:51 PM EDTStocks Rally as Crude Oil and Bond Yields SlumpThe S&P 500 Index ($SPX ) (SPY ) today is up +0.78%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.24%. June E-mini S&P futures (ESM26 ) are up +0.70%, and June E-mini Nasdaq futures…
- Zacks · May 7, 9:30 AM EDTMedline (MDLN) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesAlthough the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Zacks · Apr 14, 12:59 PM EDTMDLN Gets FDA Warning for Quality Lapses in Angiographic SyringesMDLN faces FDA warning over cGMP lapses in angiographic syringes, citing weak quality controls, CAPA gaps and design flaws despite escalating share price.
- Fintel · Mar 27, 2:55 PM EDTMedline (MDLN) Price Target Increased by 13.24% to 54.65The average one-year price target for Medline (NasdaqGS:MDLN) has been revised to $54.65 / share. This is an increase of 13.24% from the prior estimate of $48.27 dated February 21, 2026. The price target is an average of many targets provided by analysts. The
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Medline Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.